Aflibercept [vascular endothelial growth factor Trap-Eye] appears to be effective in the neovascular form of age-related macular degeneration

Source: Inpharma, Volume 1, Number 1637, 2008-05-10 , pp. 8-8(1)

Publisher: Adis International

Keywords: Aflibercept, therapeutic use; Age-related-macular-degeneration, treatment; Bayer-HealthCare; Research-and-development; Trial-result-clinical

Document Type: Short communication

Publication date: 2008-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers